VC studio conflict-of-interest: when funds incubate competitors to their own portfolio companies

Summary

VC Studio Conflict-of-Interest: When Funds Incubate Competitors to Portfolio Companies

A listener raises a sharp structural problem in venture capital: funds that run both investment operations and internal incubators create perverse incentives that can hurt founders pitching those very funds.

The question comes from Base Baron, who points to embedded VC as an example. The concern is direct: if a fund invests in an early-stage deep tech company and simultaneously runs its own studio or incubator, it can access that portfolio company's data and insights to build a competing version in-house. Why fund an external team when you can incubate a copycat and keep all the upside yourself?

The tension is real but the practical risk is often overstated.

The first layer of defense is simple: if you're building a generational company with a world-class team, the fund will back you, not incubate a competitor. Funds would much rather own a piece of a breakout success than own all of a mediocre knockoff. The incubation path is a fallback—a sign the fund didn't believe in the external team enough to write the check. As one of the hosts puts it directly: "they would so much rather just back the generational team. If you are building a generational company and you have this world class generational team, you can rest assure that the VC fund will happily just invest in your company. They will only incubate something, an alternative, if they don't believe in you."

The structural incentive is clearer than it first appears. Founders Fund, cited as a precedent, spent roughly two years searching the market for someone to build a world-class defense company before finally deciding to incubate Anduril internally. The founders fund team tried to write checks first; the incubation was not Plan A, but Plan B after the market failed to produce the team they wanted to back.

Anduril itself is instructive. The company was built by a rock-star team of former Palantir engineers and operators with deep credibility and connections in the defense space. Even though the founders told everyone what they were building, copying them proved impossible. You can't just steal a pitch deck and execute at that level. The team is the moat.

There is a real misalignment issue for certain founder archetypes: if you're pitching an idea that's on-trend, time-sensitive, or easily replicable—an AI sales tool, a CRM automation platform, something that screams "this will be copied by 10 YC companies within six months"—you should be cautious about which funds see your deck. One host recalls feedback Justin Mayers received when pitching TrueMed: "this is a good idea, but you gotta be really quiet about this for the next, like, year or 2 until you get this thing going because this is an idea that would be copied by 10 different y c companies, and you would just get sliced up." The risk is real when the barrier to entry is low and the market window is short.

But the flip side cuts both ways. One host shares a story where a candidate interviewed at a fund's incubation team, stole an idea from the incubator itself, and went to build it separately with different capital. It didn't work out—the host calls it "very stupid" and wouldn't recommend it—but it's evidence the conflict isn't unidirectional. Founders can also extract value from the VC structure and run.

The broader point: be better. If you're building something defensible with a team that can actually execute it, the incubation risk becomes moot. The fund's incentives align with backing you. If you're building something easy to copy with a team the fund doubts, then the conflict of interest is the least of your problems.